CLPT

Insider Trades

Name	Value	Action	Price	Current Price
Richards Timothy T.Director $66k5.4k shares SellJun 1, 2026 $12.17 --
Klein Matthew B.Director $185k16k shares SellMay 21, 2026 $11.59 --
Fallon Lynnette CDirector $57k5.1k shares SellMay 20, 2026 $11.14 --
Fallon Lynnette CInsider $57k5.1k shares SellMay 20, 2026 $11.14 --
Burnett JosephDirector, Officer: CEO And President $303k20k shares SellFeb 25, 2026 $15.17 --
Burnett JosephDirector, Officer: CEO And President $46k2.9k shares SellJan 26, 2026 $15.57 --

News

seekingalpha.comClearPoint Neuro: AMT-130's FDA Reversal Revives The Bull Caseseekingalpha.comJun 18

zacks.comClearPoint Neuro (CLPT) Surges 26.0%: Is This an Indication of Further Gains?zacks.comJun 18

accessnewswire.comClearPoint Neuro Enters into 10-year Focused Ultrasound Development Partnership with Sungkyunkwan University, South Korea, Further Expanding Our Drug Delivery Ecosystem and Global Footprintaccessnewswire.comMay 27

seekingalpha.comClearPoint Neuro, Inc. (CLPT) Q1 2026 Earnings Call Transcriptseekingalpha.comMay 13

zacks.comCompared to Estimates, ClearPoint Neuro (CLPT) Q1 Earnings: A Look at Key Metricszacks.comMay 13

Trade CLPT

About ClearPoint Neuro, Inc.

ClearPoint Neuro, Inc. is a medical technology firm primarily operating within the United States. The company specializes in developing and commercializing sophisticated systems that facilitate minimally invasive brain surgeries, guided by real-time magnetic resonance imaging (MRI) during the procedure. Among its core offerings is the ClearPoint system, designed for the precise placement of deep brain stimulation electrodes, biopsy needles, and for the controlled infusion of medications and laser catheters directly into the brain. It also provides the ClearPoint Neuro Navigation System, which is specifically engineered for MRI suite environments. ClearPoint Neuro maintains strategic partnerships and licensing agreements with prominent institutions and companies, including Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Neurotech, and the University of California, San Francisco. Initially established in 1998 and headquartered in Solana Beach, California, the company operated as MRI Interventions, Inc. before rebranding to ClearPoint Neuro, Inc. in February 2020.

CEO: Joseph Michael Burnett
IPO Date: May 22, 2012

Market Data

Open: $17.59
High: $18.85
Low: $16.98
Volume: 2.1M
Avg Volume: 665.2K
52W High: $30.10
52W Low: $8.27

Valuation

Market Cap: $533M
Enterprise Value: $561M
Dividend Yield: 0.00%

Financials

Free Cash Flow: $-24M
Revenue: $37M
Net Income: $-26M
Cash: $46M
Debt: $58M

Events

EarningsAug 11

EPS est. -0.27